Literature DB >> 15181250

Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis.

G William Rebeck1.   

Abstract

The risk of Alzheimer's disease and the levels of amyloid deposition are altered by factors associated with high cholesterol levels. When cells have high levels of cholesterol, they induce an efflux system of to maintain a proper cholesterol equilibrium. In the brain, cholesterol is converted to 24S hydroxycholesterol by the enzyme Cyp46. 24S hydroxycholesterol promotes gene transcription through interactions with LXR. We have found that in cells derived from the brain, two proteins important for cholesterol efflux, ABCA1 and apoE, are induced by this system. Furthermore, we have found that pharmacologic induction of LXR also induced secreted Abeta levels, particularly levels of Abeta42. We suggest that the risk of amyloid deposition associated with high cholesterol may be through induction of the LXR system. Copyright 2004 Humana Press Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181250     DOI: 10.1385/JMN:23:3:219

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  57 in total

1.  Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice.

Authors:  E Orsó; C Broccardo; W E Kaminski; A Böttcher; G Liebisch; W Drobnik; A Götz; O Chambenoit; W Diederich; T Langmann; T Spruss; M F Luciani; G Rothe; K J Lackner; G Chimini; G Schmitz
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

Review 2.  Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer disease.

Authors:  Benjamin Wolozin
Journal:  Arch Neurol       Date:  2003-01

3.  24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.

Authors:  A Papassotiropoulos; D Lütjohann; M Bagli; S Locatelli; F Jessen; R Buschfort; U Ptok; I Björkhem; K von Bergmann; R Heun
Journal:  J Psychiatr Res       Date:  2002 Jan-Feb       Impact factor: 4.791

4.  Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.

Authors:  Gloria Lena Vega; Myron F Weiner; Anne M Lipton; Klaus Von Bergmann; Dieter Lutjohann; Carol Moore; Doris Svetlik
Journal:  Arch Neurol       Date:  2003-04

5.  Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes.

Authors:  G W Rebeck; N C Alonzo; O Berezovska; S D Harr; R B Knowles; J H Growdon; B T Hyman; A J Mendez
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

6.  Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Authors:  L M Refolo; B Malester; J LaFrancois; T Bryant-Thomas; R Wang; G S Tint; K Sambamurti; K Duff; M A Pappolla
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

7.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

8.  Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury.

Authors:  A M Fagan; B A Murphy; S N Patel; J F Kilbridge; W C Mobley; G Bu; D M Holtzman
Journal:  Exp Neurol       Date:  1998-06       Impact factor: 5.330

Review 9.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

10.  Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration.

Authors:  Ling Wang; Gertrud U Schuster; Kjell Hultenby; Qinghong Zhang; Sandra Andersson; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

View more
  8 in total

1.  Prostaglandin A1 Inhibits the Cognitive Decline of APP/PS1 Transgenic Mice via PPARγ/ABCA1-dependent Cholesterol Efflux Mechanisms.

Authors:  Guo-Biao Xu; Liu-Qing Yang; Pei-Pei Guan; Zhan-You Wang; Pu Wang
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

2.  A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.

Authors:  Giselle P Lim; Frédéric Calon; Takashi Morihara; Fusheng Yang; Bruce Teter; Oliver Ubeda; Norman Salem; Sally A Frautschy; Greg M Cole
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

3.  The N-Terminus of Human Sulfotransferase 2B1b─a Sterol-Sensing Allosteric Site.

Authors:  Ian Cook; Thomas S Leyh
Journal:  Biochemistry       Date:  2022-05-06       Impact factor: 3.321

4.  24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury.

Authors:  Casandra M Cartagena; Mark P Burns; G William Rebeck
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252

Review 5.  Liver X receptors, nervous system, and lipid metabolism.

Authors:  G Cermenati; E Brioschi; F Abbiati; R C Melcangi; D Caruso; N Mitro
Journal:  J Endocrinol Invest       Date:  2013-04-18       Impact factor: 4.256

Review 6.  Cholesterol in brain disease: sometimes determinant and frequently implicated.

Authors:  Mauricio G Martín; Frank Pfrieger; Carlos G Dotti
Journal:  EMBO Rep       Date:  2014-09-15       Impact factor: 8.807

Review 7.  Cholesterol metabolism and homeostasis in the brain.

Authors:  Juan Zhang; Qiang Liu
Journal:  Protein Cell       Date:  2015-02-15       Impact factor: 14.870

8.  Large-scale sequencing studies expand the known genetic architecture of Alzheimer's disease.

Authors:  Diane Xue; William S Bush; Alan E Renton; Edoardo A Marcora; Joshua C Bis; Brian W Kunkle; Eric Boerwinkle; Anita L DeStefano; Lindsay Farrer; Alison Goate; Richard Mayeux; Margaret Pericak-Vance; Gerard Schellenberg; Sudha Seshadri; Ellen Wijsman; Jonathan L Haines; Elizabeth E Blue
Journal:  Alzheimers Dement (Amst)       Date:  2021-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.